Sami Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 05-11-2024
- Paid Up Capital ₹ 50.00 Cr
as on 05-11-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 145.00 Cr
as on 05-11-2024
- Revenue -80.88%
(FY 2023)
- Profit -301.64%
(FY 2023)
- Ebitda -2378.84%
(FY 2023)
- Net Worth -24.99%
(FY 2023)
- Total Assets -0.74%
(FY 2023)
About Sami Nutraceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 50.00 Cr.
The company currently has active open charges totaling ₹145.00 Cr.
The Key Managerial Personnel (KMP) at Sami Nutraceuticals Private Limited India is Devendra Gupta as COMPANY SECRETARY. Anju Majeed and Shaheen Majeed serve as directors at the Company.
- CIN/LLPIN
U15490KA2020PTC133889
- Company No.
133889
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sami Nutraceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Devendra Gupta | Company Secretary | 30-May-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anju Majeed  | Director | 24-Apr-2020 | Current |
Shaheen Majeed  | Additional Director | 23-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Sami Nutraceuticals.
Sami Nutraceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 80.88% decrease. The company also saw a substantial fall in profitability, with a 301.64% decrease in profit. The company's net worth observed a substantial decline by a decrease of 24.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sami Nutraceuticals?
In 2023, Sami Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sami-Sabinsa Group LimitedActive 33 years 8 monthsAnju Majeed, Shaheen Majeed and 1 more are mutual person
Organica Aromatics Private LimitedActive 25 years 4 monthsAnju Majeed and Shaheen Majeed are mutual person
Mm Corporate Security Services Private LimitedActive 17 years 2 monthsAnju Majeed and Shaheen Majeed are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 28 Aug 2020 | ₹145.00 Cr | Open |
How Many Employees Work at Sami Nutraceuticals?
Sami Nutraceuticals has a workforce of 80 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sami Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sami Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
